Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Exciting Advancements Underway in Ovarian Cancer

July 14th 2018, 11:56pm

Article

New treatments are continually being explored as researchers use genetic testing and genomic sequencing to better understand characteristics of ovarian cancer that can be targeted with drugs.

The Future of Ovarian Cancer: PARP Inhibition 'Leading the Way'

July 6th 2018, 8:57pm

Article

PARP inhibitors have made for new and exciting treatment options for ovarian cancer, but there is still much more work to be done, according to Dennis J. Slamon, M.D., Ph.D.

Examining Early-Life Adversity and the 'Stress Hormone' in Ovarian Cancer Survivors

July 3rd 2018, 11:03pm

Article

Adversity early on in life and increased stress levels could impact ovarian cancer outcomes – even if these instances happen before a woman is diagnosed, according to a recent article published in the journal Cancer.

CURE's Top 5 Stories: June 2018

July 2nd 2018, 6:00pm

Article

Take a look at the top five CURE stories of June 2018 in this video.

Lynparza Prolongs Disease Progression in Advanced Ovarian Cancer

June 29th 2018, 9:06pm

Article

PARP inhibitors continue to impress in the ovarian cancer space, as findings from the recent phase 3 SOLO-1 trial showed that Lynparza (olaparib) showed clinically-meaningful improvement in progression-free survival (PFS) when used in the first-line maintenance setting.

Exploring Another Biomarker in Ovarian Cancer

June 26th 2018, 10:35pm

Video

Folate receptor alpha was a promising biomarker when it came to treatment with mirvetuximab soravtansine.

Majority of Women With Ovarian Cancer Feel Uncomfortable Raising Psychological Concerns

June 25th 2018, 5:15pm

Article

A recent review of data found that 79 percent of patients with ovarian cancer felt uncomfortable raising psychological and emotional concerns during their consultations.

Zejula Shows Potential as More Than Just Maintenance Therapy

June 24th 2018, 12:10am

Article

In the QUADRA study, treatment with Zejula (niraparib) demonstrated durable responses among women with relapsed or refractory ovarian cancer, regardless of BRCA mutation.

Testing Only the 'Tip of the Iceberg' for Common Hereditary Condition in MSI-H Tumors

June 14th 2018, 10:55pm

Article

Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

FDA Approves Avastin Regimen for Ovarian Cancer Treatment

June 13th 2018, 8:10pm

Article

The Food and Drug Administration approved a combination of Avastin (bevacizumab) plus the chemotherapy agents carboplatin and paclitaxel, followed by Avastin alone, for the treatment of patients with advanced ovarian cancer who have had surgical resection.